Liu Ye - Net Worth and Insider Trading
Liu Ye Net Worth
The estimated net worth of Liu Ye is at least $376 Million dollars as of 2024-09-24. Liu Ye is the 2101 Beneficial owner of Ocumension Therapeutics and owns about 76,112,990 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $376 Million. Details can be seen in Liu Ye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Liu Ye has not made any transactions after 2024-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Liu Ye
Liu Ye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Liu Ye owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Click here to see the complete history of Liu Ye’s form 4 insider trades.
Insider Ownership Summary of Liu Ye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-01-10 | 2101 Beneficial owner |
Liu Ye Latest Holdings Summary
Liu Ye currently owns a total of 1 stock. Liu Ye owns 76,112,990 shares of Ocumension Therapeutics (HKSE:01477) as of January 10, 2024, with a value of $376 Million.
Latest Holdings of Liu Ye
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-01-10 | 76,112,990 | 4.94 | 375,998,171 |
Holding Weightings of Liu Ye
Liu Ye Form 4 Trading Tracker
According to the SEC Form 4 filings, Liu Ye has made a total of 15 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ocumension Therapeutics is the sale of 0 shares on January 10, 2024, which brought Liu Ye around $0.
Insider Trading History of Liu Ye
- 1
Liu Ye Trading Performance
Liu Ye Ownership Network
Ownership Network List of Liu Ye
Ownership Network Relation of Liu Ye
Liu Ye Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
Liu Ye is the 2101 Beneficial owner of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you Temasek Holdings (private) Limited , 2201 Interest of corporation controlled by you Boyu Capital Group Holdings Ltd , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, Liu Ye made 8 insider transaction in Ocumension Therapeutics (HKSE:01477) with a net sale of 500. Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , a net sale of 427,000 shares made by The Capital Group Companies, Inc. , and a net purchase of 150,000 shares made by Boyu Capital Group Holdings Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,227,500 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,500 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
Liu Ye Mailing Address
Above is the net worth, insider trading, and ownership report for Liu Ye. Currently GuruFocus does not have mailing address information for Liu Ye.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
